Notably, attention is surfacing within the UK regarding the drug as a promising therapy for lipodystrophy . While largely recent, awareness of what it can do – particularly in addressing the consequences of HIV-related lipodystrophy – is gaining. Specialists are investigating its use , and patient inquiries is increasing , suggesting that this